SEARCH RESULTS FOR: "Tag: AXSM"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(3)
2018(1)
CATEGORIES
Analyst Update(2)
Buzz Stocks(2)
Intraday Option Activity(1)
Stocks On the Move(1)

5/28/2019 11:11 AM
Axsome Therapeutics Inc (NASDAQ:AXSM) presented data on AXS-05 at the American Psychiatric Association (APA) conference this weekend, and analysts are rewarding the equity today. Cantor Fitzgerald h...
5/6/2019 9:55 AM
Near the top of the Nasdaq today sits Esperion Therapeutics Inc (NASDAQ:ESPR), after the Food and Drug Administration (FDA) accepted marketing applications for the company's cholesterol drug. At last...
1/7/2019 9:57 AM
The shares of penny stock Axsome Therapeutics Inc (NASDAQ:AXSM) are up a whopping 164.4% at $6.95 in early trading, after the company's experimental depression drug, AXS-05, realized its main goal in...
10/17/2018 2:51 PM
Stocks are trading lower today, pulling back some from yesterday's impressive rally. Meanwhile, casino concern Caesars Entertainment Corporation (NASDAQ:CZR) and biopharma name Axsome Therapeutics ...
PEOPLE ALSO SEARCH FOR

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center